TickerFacts.

Company research / FMS

Fresenius Medical Care AG (FMS)

Also trades as FMCQF. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

CIK 0001333141 · NYSE · Services-Misc Health & Allied Services, NEC

  • Sector Services

Not updated since 2016-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Key ratios (year ended 2016-12-31)

10.9%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-10-07

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenuen/an/a$5.27B$4.97Bn/an/an/an/an/an/a
Cost of Revenue$12.13B$11.41B$10.84B$9.87B$9.20B$8.42B$8.01B$7.42B$6.98B$6.36B
Gross Profit$5.78B$5.33B$5.00B$4.74B$4.60B$4.15B$3.84B$3.83B$3.63B$3.36B
R&D Expense$162.36M$140.30M$122.11M$125.81M$111.63M$110.83M$96.53M$93.81M$80.24M$66.52M
Operating Income$2.64B$2.33B$2.25B$2.26B$2.22B$2.07B$1.92B$1.76B$1.67B$1.58B
Depreciation & Amortization$775.95M$717.32M$699.33M$648.23M$602.90M$557.28M$503.22M$457.08M$415.67M$363.33M
EBITDA$3.41B$3.04B$2.95B$2.90B$2.82B$2.63B$2.43B$2.21B$2.09B$1.94B
Net Income$1.24B$1.03B$1.05B$1.11B$1.19B$1.07B$978.52M$891.14M$817.61M$717.13M
EPS (Diluted)$4.06$3.38$3.45$3.65$3.87$3.51$3.24$2.99$2.74$2.42
Total Assets$26.93B$25.37B$25.38B$23.12B$22.33B$19.53B$17.09B$15.82B$14.92Bn/a
Total Liabilities$14.24B$13.84B$14.53B$12.99B$12.60B$11.06B$9.29B$8.79B$8.80Bn/a
Shareholders' Equity$11.46B$10.50B$10.03B$9.49B$9.21B$8.06B$7.52B$6.80B$5.96B$5.68B
Cash & Equivalents$747.23M$549.50M$633.86M$682.78M$688.04M$457.29M$522.87M$301.23M$221.58M$244.69M
Operating Cash Flow$2.14B$1.96B$1.86B$2.03B$2.04B$1.45B$1.37B$1.34B$1.02B$1.20B
Capital Expenditures$1.03B$952.94M$931.63M$747.94M$675.31M$597.86M$523.63M$573.61M$687.36M$572.72M
Free Cash Flow$1.11B$1.01B$929.76M$1.29B$1.36B$848.63M$844.50M$765.01M$329.04M$626.85M
Dividends Paid-$277.18M-$263.24M-$317.90M-$296.13M$271.73M$280.65M$231.97M$231.94M$252.40M$188.41M
Shares Outstanding306.22M305.31M301.45M301.45M300.16M300.16M298.28M295.75Mn/an/a
Dividends Per Share$0.80$0.78$0.77n/an/an/an/an/an/an/a
Weighted Average Diluted Shares306.26M304.92M302.87M302.55M302.90M300.81M298.12M294.42M294.01Mn/a
EPS (Basic)$4.07$3.38$3.46$3.65$3.89$3.54$3.25$2.99$2.75$2.43

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView